Henry-Joyce Cancer Center is a clinical research site located in Nashville, Tennessee, United States 37232.
Crixeo Clinical Trials Trust Score: 18/100 (FAILING). This profile has not yet been claimed by the site owner.
Henry-Joyce Cancer Center has participated in 10 clinical trials with 1 currently active.
Therapeutic areas: Squamous Cell Non-small Cell Lung Cancer, Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL), Small Cell Lung Carcinoma.
Sponsors: Bristol-Myers Squibb, Kite, A Gilead Company, Amgen.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Tennessee · View every site in Nashville
Trust Score: 18/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Henry-Joyce Cancer Center has a Crixeo Trust Score of 18/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Henry-Joyce Cancer Center has 10 clinical trials on record, with 1 currently active. Their work covers Squamous Cell Non-small Cell Lung Cancer, Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL), Small Cell Lung Carcinoma.
Henry-Joyce Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.